药物洗脱支架载体材料的选择与优化

材料科学与工艺, 2004, 12(6): 610-614. doi: 10.3969/j.issn.1005-0299.2004.06.014

药物洗脱支架载体材料的选择与优化

田文彦 ^1, , 陈庆福 ^2, , 王利明 ^3, , 蔡伟 ^4,

1.辽宁工学院,材料与化学工程学院,辽宁,锦州,121001

2.辽宁工学院,材料与化学工程学院,辽宁,锦州,121001;法尔胜集团公司,江苏,江阴,214433

3.法尔胜集团公司,江苏,江阴,214433

4.哈尔滨工业大学,生物医学材料与器件研究所,黑龙江,哈尔滨,150006

关键词：药物洗脱支架 , 载体材料 , 涂层 , 优化,控制释放

Selection and optimization of drug-carrier materials of DES

对药物洗脱支架药物载体材料和支架涂层进行了综述,指出了药物载体材料的选择范围,提出了药物载体材料的优化原则、药物配合的条件以及药物载体材料的发展方向.

参考文献

[1]	2003年度科技型中小企业技术创新基金若干重点项目指南[OL].http://www:innofund:gov:cn 2003
[2]	李广平.实用临床心脏病诊断治疗学[M].北京:中国医药科技出版社,2002
[3]	韩雅玲.心血管病介入诊断治疗新视角-2003[M].沈阳:辽宁科学技术出版社,2003
[4]	LEONMartin;ALEXANDRE Abizaid;MOSES Jeffrey W .The CYPHERTM Stents: A new Gold Standard in the Treatment of Coronary Artery Disease[EB/OL].http:∥www: Socime: Orgmx/cardio/industria/cypher: Pdf,2004 -03 - 19
[5]	JohnsonJohnson-Cordis .Aqua T3[DB/CD].Shanghai International Interventional Cardiovascular Therapeutics, 2004
[6]	JohnsonJohnson-Cordis .CypherTM 与冠心病防治[DB/CD].Shanghai International Interventional Cardiovascular Therapeutics,2004.
[7]	CHONGPangH;CHENG Judy WM .Early experiences and clinical implications of drug-eluting stents[OL].http://www.theannals:com,2004-02-06.
[8]	时钧;袁权;高从锴.膜技术手册[M].北京:化学工业出版社,2001
[9]	Debiotech obtains exclusive rights to an innovative drug eluting stent technology[EB/OL].http://www:Debiotech:Com/news/nw_133:Html2003-03-07
[10]	TAMAIHideo;IGAKI Keiji;KYO Eisho et al.Clinical Investigation and Reports:[OL].http://circ:ahajournals:org/cgi/content2000
[11]	Frontlinestrategicconsulting Inc .Drug-Eluting Stents:Physician Perspectives and Opportunity Analysis of a High Growth Market in 2003[OL].http://www:frontlinesmc:com/SMR/DES/DESTOC:pdf2003
[12]	HEULEIN;ROHDE R;KAESE V et al.Biocorrosionofmagnesiumalloys:anewprincipleincardiovascularimplanttechnology?Biosensor'sAgreement/DrugElutingStentUpdate-FinalFairDisclosureWire[J].HEART,2003,89:651-656.
[13]	HEXACATH.TITANOX COATED 钛一氧化氮涂层支架[A].上海,2004
[14]	Sorin Biomedica SYNCRO Carbo-stent[A].上海,2004
[15]	Sorin Medical Technology[EB/OL].http://www:Snia:It/pdf/SniaIstituzionale,2003.
[16]	RAUN B B.贝朗心血管产品PTCA系列[A].上海,2004
[17]	FDA Approves Drug-Eluting Stent for Clogged Heart Arteries[OL].http://www: fda: gov/bbs/topics/NEWS/2003/NEW00896: html,2003-04-24.
[18]	Guidant Provides Overview of Drug Eluting Stent Program[EB/OL].http://www:guidant:com/news/400/webrelease/nr000433:shtml,2003-11-19.
[19]	Guidant Gains Immediate Access to Drug Eluting Stent Market[EB/OL].http:∥www: Guidant: Com/webcast,2004-02-24.
[20]	Boston Scientific reports zero restenosis in drug-eluting stent trial[OL].http://www: globalteehnosean:com/10thOct-16thOct01/restenosis: htm,2001-10-10.
[21]	MicroPort 2004 Shanghai International Interventional Cardiology Therapeutics Seminar[EB/OL].http://www.Microportmedical.Com,2004-03-19.
[22]	Lifetech, 2004 Shanghai International Interventional Cardiology Therapeutics Seminar[EB/OL].http://www:Lifetech:Com,2004-03-19.
[23]	PRESCOTTLawrenceM .The Viewpoint of Interventional Cardiologists[EB/OL].http://www:bioportfolio:com/reports/DMD_stent:htm,2004-04-02.

上一张下一张

计量

下载量()
访问量()

作者相关

文章评分

您的评分：
1

0%
2

0%
3

0%
4

0%
5

0%

材料期刊网

药物洗脱支架载体材料的选择与优化

Selection and optimization of drug-carrier materials of DES

参考文献